Spideyboy Thursday, 05/28/20 03:51:06 AM Re: midastouch017 post# 346 Post # of 373 I hope it bodes well for you, PLX is my largest holding. My only curiosity is how long can the clinical data not be appreciated! Hopefully things look up on the earnings call on Monday. Indeed I am following RDHL. Listened to the earnings call. I think things are trucking along smoothly for them. I know people were disappointed to not have a clear view of Talicia uptake, but I don't see this a concern. Talicia's clinical data is fantastic a no-brainer if you will. The product price is below what I would have expected but has obviously helped to get them on payers books and preferred formularies and the physicians should be happy. So it looks like it was a good call. People also disappointed perhaps to hear the next clinical trials being delayed, but when only by 1 quarter I think that's fine. And just means more Movantik and Talicia money in the bank when the trial begin, which is always nice. RDHL is one that I will keep adding to, as while it won't have the same % increase potential as PLX (due to PLX's lower market cap), I feel the RDHL market cap is undervalued with still very good % gains to be made and most importantly that it is as safe as it's going to get. Can I ask, any reason why added to PLX TASE and not Nasdaq?